This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising. Disclosure: This does not represent material news, partnerships or investment…
-
-
Investing
Tartisan Nickel Corp. Intersects 24.6 Metres of 0.71% Ni, 0.56% Cu Including 6.1 Metres of 1.17% Ni, 1.45% Cu at the Kenbridge Nickel-Copper-Cobalt Project, Northwestern Ontario
Tartisan Nickel Corp. (CSE: TN,OTC:TTSRF) (OTCQX: TTSRF) (FSE: 8TA) (‘Tartisan’, or the ‘Company’) is pleased to provide an update on the Phase…
-
Investing
Cartier Cuts 7.1 g/t Au over 8.0 m at Portal ; New Shallow High-Grade Gold Zone Discovered
Cartier Resources Inc. (″ Cartier ″ or the ″ Company ″) (TSXV: ECR,OTC:ECRFF; FSE: 6CA) is pleased to announce the ninth batch…
-
South African gold producer Pan African Resources (LSE:PAF) has agreed to acquire Australian explorer Emmerson (LSE:EML) in an all-share transaction valued at…
-
Palo Alto-based startup Rhoda AI announced that it has raised US$450 million in a Series A funding round, valuing the company at…
-
TORONTO, ON / ACCESS Newswire / March 11, 2026 / AmeriTrust Financial Technologies Inc. (TSXV:AMT,OTC:AMTFF)(OTCQB:AMTFF)(Frankfurt:1ZVA) (‘AmeriTrust‘, ‘AMT‘ or the ‘Company‘), a fintech…
-
Investing
Silver Hammer Prepares for Drill Program at Its 100% Owned California Patented Claim at The Eliza Project in Nevada
Silver Hammer Mining Corp. (CSE: HAMR,OTC:HAMRF) (the ‘Company’ or ‘Silver Hammer’) is pleased to announce that the Company is finalizing plans for…
-
Global energy officials are weighing the largest coordinated release of emergency oil reserves ever proposed as supply disruptions linked to the ongoing…
-
Investing
Homerun Resources Inc. and UC Davis Produce Fused Silica Glass from SME Silica Sand Using Fast Joule Heating and File Patent Application for Femtosecond Silica Purification Process
Homerun Resources Inc. (TSXV: HMR,OTC:HMRFF) (OTCQB: HMRFF) (‘Homerun’ or the ‘Company’) is pleased to announce that researchers at the University of California, Davis (‘UC…
-
Solvonis Therapeutics plc (LSE: SVNS), an emerging biopharmaceutical company developing novel small-molecule therapeutics for high-burden central nervous system (‘CNS’) disorders, announces the…
